- Ascendis Pharma (ASND) is scheduled to announce Q2 earnings results on Tuesday, September 3rd, after market close.
- The consensus EPS Estimate is -$1.55 (+28.2% Y/Y) and the consensus Revenue Estimate is $93.81M (+98.0% Y/Y).
- Over the last 1 year, ASND has beaten EPS estimates 0% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 3 upward revisions and 4 downward. Revenue estimates have seen 0 upward revisions and 5 downward.
